$26.52 -1.25 (-4.50%) Emergent BioSolutions Inc - New York Stock Exchange, Inc.

Dec. 7, 2016 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 26.52
Trade Time: Dec 07 04:00 PM Eastern Daylight Time
Change: -1.25 (-4.50%)
Prev Close: 27.77
Open: 27.41
Bid: 24.20
Ask: 31.47
  1. No results found.
  1. Anthrax Vaccine Maker Emergent Hopes To Profit From Biotech Spinoff

    IBD | Feb. 12, 2016 | 15:35PM EST
  2. Stocks Rise, As Techs Set The Pace; Criteo Spikes; SolarCity Dives

    IBD | Feb. 10, 2016 | 10:44AM EST
  3. Odd Bedfellows Emerge In The IBD 50

    IBD | Feb. 5, 2016 | 18:26PM EST
  4. Emergent BioSolutions Announces Favorable IRS Private Letter Ruling Regarding Biosciences Business Spin-Off

    Benzinga | Jan. 10, 2016 | 18:11PM EST
  5. Weekly CEO Sales Highlight: Realpage, Anadigics, Emergent BioSolutions, ScanSource

    GuruFocus | Jan. 3, 2016 | 21:09PM EST
  6. Emergent BioSolutions Announces Composition of Board of Directors of New Spin-Off Company Aptevo Therapeutics

    Benzinga | Dec. 22, 2015 | 16:02PM EST
  7. Biotechs Weaken, But These Names Have Bullish Charts

    IBD | Nov. 25, 2015 | 17:19PM EST
  8. Anthrax Vaccine Maker Becomes New Stock Market Leader

    IBD | Nov. 13, 2015 | 16:59PM EST
  9. Vista Partners Updates Coverage on Soligenix, Inc. (Ticker: SNGX); Price Target $7.00

    GuruFocus | Sep. 24, 2015 | 23:02PM EST
  10. Emergent BioSolutions Receives $44M CDC Contract to Further Advance Vaccinia Immune Globulin Intravenous Program

    Benzinga | Aug. 13, 2015 | 06:03AM EST
  11. Emergent BioSolutions to Spin-Off of Biosciences Business Into Separate Publicly-Traded Company in Tax-Free Transaction

    Benzinga | Aug. 6, 2015 | 06:11AM EST
  12. UPDATE: Emergent Biosolutions Announces $19.7M Contract

    Benzinga | Jul. 20, 2015 | 06:15AM EST
  13. US Stock Futures Down Ahead Of Jobless Claims

    Benzinga | May. 28, 2015 | 07:05AM EST
  14. ProMetic Life Science to Acquire Emergent Biosolutions' Plasma Collection Center in Winnipeg, Canada

    Benzinga | May. 28, 2015 | 06:20AM EST
  15. Emergent BioSolutions Awarded $29M 5-Year Contract To Develop A Dry Formulation Of NuThrax, A Next Generation Anthrax Vaccine

    Benzinga | Sep. 8, 2014 | 12:54PM EST
Trading Center